Effekt von Sirolimus auf Malignome und Überlebensrate nach NTx – Systematische Metaanalyse individueller Patientendaten

Quelle: Knoll GA, Kokolo MB, Mallick R et al. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. BMJ 2014; 349: g6679

• Literatur

• 1 Lebranchu Y, Thierry A, Thervet E et al. Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study. Am J Trans 2011; 11: 1665-1675
• 2 Webster AC, Lee VW, Chapman JR, Craig JC et al. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation 2006; 81: 1234-1248
• 3 Kahan BD. Sirolimus: a comprehensive review. Expert Opinion Pharmacother 2001; 2: 1903-1917